Numerous studies have shown that IDH1/IDH2 mutations frequently occur in low-grade gliomas7, secondary glioblastoma8, chondrosarcoma9, acute myeloid leukemia (AML)10, and intrahepatic cholangiocarcinoma11. Here, IDH1 is linked to acute myeloid leukemia.